Background Glioma is the primary cancer of the central nervous system, and defining the
prognosis of glioma is of great significance in the clinical. The long noncoding RNAs …

Background Long non-coding RNAs (lncRNAs) have been verified to have a vital role in the
progression of glioblastoma multiforme (GBM). Our research was about to identify the …

Background As immunotherapy has received attention as new treatments for brain cancer,
the role of inflammation in the process of glioma is of particular importance. Increasing …

Glioma is the most common and fatal primary brain tumor in human. Long non-coding RNA
(lncRNA), which are characterized by regulation of gene expression and chromatin …

Long non-coding RNAs have been shown to be associated with cancer development and
progression, demonstrating potential applications as novel diagnostic or prognostic …

Recent studies have demonstrated the utility and superiority of long non-coding RNAs
(lncRNAs) as novel biomarkers for cancer diagnosis, prognosis, and therapy. In the present …

Background To accurately predict the prognosis of glioma patients. Methods A total of 541
samples from the TCGA cohort, 181 observations from the CGGA database and 91 samples …

Gliomas account for 75% of the primary malignant brain tumors and a majority of lower-
grade gliomas (LGG) inevitably develop into glioblastoma. The dysregulation of lncRNAs …

Glioblastoma (GBM), a primary malignant tumor of the central nervous system, has a very
poor prognosis. Analysis of global GBM samples has revealed a variety of long non-coding …

Background Gliomas are the most lethal type of primary brain tumor in adult. Long
noncoding RNAs (lncRNAs), which are involved in the progression of various cancers, may …